| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |